Novartis Ag (NVS) Treasury Shares (2009 - 2026)

Novartis Ag's Treasury Shares history runs 13 years deep, the most recent figure standing at -$47.0 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 147.37% year-over-year to -$47.0 million; the TTM figure through Mar 2026 stood at -$47.0 million (down 147.37% YoY), while the FY2025 annual figure was -$50.0 million, up 5.66% from the prior year.
• Treasury Shares came in at -$47.0 million for Q1 2026 at Novartis Ag, up from -$50.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $92.0 million in Q4 2022 to a low of -$70.0 million in Q3 2022.
• A 5-year average of -$29.7 million and a median of -$40.0 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares surged 91.67% in 2022 and tumbled 229.27% in 2024, its largest moves.
• Novartis Ag's Treasury Shares stood at $92.0 million in 2022, then sank by 55.43% to $41.0 million in 2023, then sank by 229.27% to -$53.0 million in 2024, then climbed by 5.66% to -$50.0 million in 2025, then advanced by 6.0% to -$47.0 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered -$47.0 million, -$50.0 million, and -$44.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison